Esteban Mezey

Esteban Mezey's AcademicInfluence.com Rankings

Esteban Mezey

Philosophy

#7578

World Rank

#10812

Historical Rank

Logic

#4628

World Rank

#5945

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Esteban Mezey's Degrees

Doctorate Medicine University of Buenos Aires

Why Is Esteban Mezey Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Esteban Mezey's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Corticosteroid therapy of alcoholic hepatitis (1978) (546)
Transforming Growth Factor-β1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro* (2007) (358)
Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. (2004) (346)
Aging and ethanol metabolism (1977) (344)
Inositol Pyrophosphates Inhibit Akt Signaling, Thereby Regulating Insulin Sensitivity and Weight Gain (2010) (293)
Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. (1990) (287)
Corticosteroid therapy of alcoholic hepatitis. (1978) (277)
Sampling variability on percutaneous liver biopsy. (1979) (276)
Decreased jejunal uptake of labeled folic acid ( 3 H-PGA) in alcoholic patients: roles of alcohol and nutrition. (1971) (194)
Distribution of ethanol in the human gastrointestinal tract. (1973) (191)
Human bile contains MicroRNA‐laden extracellular vesicles that can be used for cholangiocarcinoma diagnosis (2014) (186)
Transdifferentiation of rat hepatic stellate cells results in leptin expression. (1998) (181)
A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. (2004) (161)
Sex difference in alcohol-related organ injury. (2001) (138)
Effect of ethanol administration on hepatic ethanol and drug-metabolizing enzymes and on rates of ethanol degradation. (1971) (132)
Intestinal malabsorption in folate-deficient alcoholics. (1973) (124)
The inhibitory effect of ethanol on retinol oxidation by human liver and cattle retina. (1971) (118)
Relationship between pyridoxal 5'-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. (1984) (115)
The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans (2016) (115)
Ethanol metabolism and ethanol-drug interactions. (1976) (114)
Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity. (2019) (113)
Rates of ethanol clearance and activities of the ethanol-oxidizing enzymes in chronic alcoholic patients. (1971) (107)
Endogenous ethanol production and hepatic disease following jejunoileal bypass for morbid obesity. (1975) (105)
MicroRNA down‐regulated in human cholangiocarcinoma control cell cycle through multiple targets involved in the G1/S checkpoint (2011) (104)
Alcohol and dietary intake in the development of chronic pancreatitis and liver disease in alcoholism. (1988) (103)
Pancreatic function and intestinal absorption in chronic alcoholism. (1970) (102)
Effect of parenteral amino acid supplementation on short‐term and long‐term outcomes in severe alcoholic hepatitis: A randomized controlled trial (1991) (100)
Extracellular vesicles carry microRNA‐195 to intrahepatic cholangiocarcinoma and improve survival in a rat model (2017) (99)
Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma (2012) (94)
Liver disease and nutrition (1978) (91)
FAMILIAL HEMOCHROMATOSIS: CHARACTERISTICS OF THE PRE‐CIRRHOTIC STAGE IN A LARGE KINDRED (1977) (89)
Effect of parenteral amino acid supplementation in alcoholic hepatitis (1985) (87)
Dietary fat and alcoholic liver disease (1998) (85)
More rapid elimination of alcohol in women as compared to their male siblings. (1989) (80)
Histone deacetylase inhibition suppresses the transforming growth factor β1–induced epithelial‐to‐mesenchymal transition in hepatocytes (2010) (79)
Regulation of natural killer activity in vivo. II. The effect of alcohol consumption on human peripheral blood natural killer activity (1980) (78)
Effects of castration and testosterone administration on rat liver alcohol dehydrogenase activity. (1980) (76)
INTESTINAL FUNCTION IN CHRONIC ALCOHOLISM * (1975) (73)
Ethanol oxidation by a component of liver microsomes rich in cytochrome P-450. (1973) (69)
Leptin enhances the effect of transforming growth factor beta in increasing type I collagen formation. (2002) (67)
Metabolic effects of alcohol. (1985) (65)
Activation of liver X receptor/retinoid X receptor pathway ameliorates liver disease in Atp7B−/− (Wilson disease) mice (2015) (65)
Effects of retinoic acid on the development of liver fibrosis produced by carbon tetrachloride in mice. (2007) (63)
Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration (2008) (63)
Increased ethanol‐inducible cytochrome P450‐2E1 and cytochrome P450 isoforms in exosomes of alcohol‐exposed rodents and patients with alcoholism through oxidative and endoplasmic reticulum stress (2017) (61)
1,25‐dihydroxyvitamin D3 and its nuclear receptor repress human α1(I) collagen expression and type I collagen formation (2013) (61)
Pseudogene INTS6P1 regulates its cognate gene INTS6 through competitive binding of miR-17-5p in hepatocellular carcinoma (2015) (61)
Transforming growth factor-beta1 up-regulation of human alpha(1)(I) collagen is mediated by Sp1 and Smad2 transacting factors. (2009) (58)
Duration of the enhanced activity of the microsomal ethanol-oxidizing enzyme system and rate of ethanol degradation in ethanol-fed rats after withdrawal. (1972) (57)
Increased liver-specific proteins in circulating extracellular vesicles as potential biomarkers for drug- and alcohol-induced liver injury (2017) (57)
The upstream stimulatory factor binds to and activates the promoter of the rat class I alcohol dehydrogenase gene. (1991) (57)
Effect of ethanol on motility of the small intestine. (1974) (56)
Alcoholic liver disease: roles of alcohol and malnutrition. (1980) (55)
Interaction between alcohol and nutrition in the pathogenesis of alcoholic liver disease. (1991) (55)
Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis (2021) (54)
Silencing of miR-370 in Human Cholangiocarcinoma by Allelic Loss and Interleukin-6 Induced Maternal to Paternal Epigenotype Switch (2012) (53)
Influence of leptin in the development of hepatic fibrosis produced in mice by Schistosoma mansoni infection and by chronic carbon tetrachloride administration. (2003) (52)
Erythrocyte aldehyde dehydrogenase activity in alcoholism. (1984) (52)
Hepatic collagen proline hydroxylase activity in alcoholic liver disease. (1976) (51)
Changes in hepatic collagen metabolism in rats produced by chronic ethanol feeding. (1977) (49)
Characteristics of alcohol dehydrogenase in fat-storing (Ito) cells of rat liver. (1988) (49)
Effects of ethanol and acetaldehyde on reactive oxygen species production in rat hepatic stellate cells. (2006) (48)
Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy. (2013) (48)
Measurement of alcohol-related effects in man: chronic effects in relation to levels of alcohol consumption. Part A. (1977) (47)
Activation by acetaldehyde of the promoter of the mouse alpha2(I) collagen gene when transfected into rat activated stellate cells. (1996) (47)
Effect of stress by repeated immobilization on hepatic alcohol dehydrogenase activity and ethanol metabolism. (1979) (46)
Current Management of Alcoholic Hepatitis and Future Therapies (2016) (43)
Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration (2009) (42)
Rat liver alcohol dehydrogenase activity: effects of growth hormone and hypophysectomy. (1979) (41)
Effects of Thyroidectomy and Triiodothyronine Administration on Rat Liver Alcohol Dehydrogenase (1981) (41)
Evidence for free radical-mediated lipid peroxidation at reperfusion of human orthotopic liver transplants. (1994) (40)
Effects of Helicobacter pylori infection and gastritis on gastric alcohol dehydrogenase activity. (1994) (38)
Selenium Supplementation Decreases Hepatic Fibrosis in Mice After Chronic Carbon Tetrachloride Administration (2009) (38)
Effect of Chronic Ethanol Feeding on Hepatic Mitochondria in the Monkey (2007) (38)
Serum gamma-glutamyl transpeptidase and chronic alcoholism. Influence of alcohol ingestion and liver disease. (1985) (36)
Depression of alcohol dehydrogenase activity in rat hepatocyte culture by dihydrotestosterone. (1986) (36)
Xanthine oxidase activity in rat brain. (1973) (35)
Serum gamma-glutamyl transpeptidase and chronic alcoholism (1985) (35)
Hepatic collagen proline hydroxylase activity in alcoholic hepatitis: effect of d-penicillamine. (1979) (35)
Acetaldehyde activates the promoter of the mouse α2(I) collagen gene (1994) (35)
Effects of acetaldehyde on nuclear protein binding to the nuclear factor I consensus sequence in the α2(I) collagen promoter (1995) (34)
Influence of male hormones on rates of ethanol elimination in man (1988) (34)
Identification of a Novel NF-κB-binding Site with Regulation of the Murine α2(I) Collagen Promoter* (2004) (33)
Serum alcohol dehydrogenase, an indicator of intrahepatic cholestasis. (1968) (33)
Regulation of the murine α2(I) collagen promoter by retinoic acid and retinoid X receptors (2002) (33)
Acetaldehyde enhances murine alpha2(I) collagen promoter activity by Ca2+-independent protein kinase C activation in cultured rat hepatic stellate cells. (1999) (33)
MicroRNA-224 Induces G1/S Checkpoint Release in Liver Cancer (2015) (32)
Sex differences in gastric alcohol dehydrogenase activity in Sprague-Dawley rats. (1992) (31)
Effect of Chronic Ethanol Feeding on Hepatic Collagen in the Monkey (2007) (30)
Analysis of pyridine dinucleotides in cultured rat hepatocytes by high-performance liquid chromatography. (1989) (30)
Lobular distribution of alcohol dehydrogenase in the rat liver (1988) (30)
CCAAT/Enhancer Binding Protein β Mediates the Activation of the Murine α1(I) Collagen Promoter by Acetaldehyde (2000) (30)
Liver disease and protein needs. (1982) (30)
Effect of Dihydrotestosterone on Rat Liver Alcohol Dehydrogenase Activity (2007) (29)
Effect of Ethanol on Intestinal Morphology, Metabolism, and Function (1985) (29)
Effect of ethanol administration on the activity of hepatic lysosomal enzymes. (1976) (28)
Separation and partial characterization of multiple forms of rat liver alcohol dehydrogenase. (1983) (28)
Vitamin E and porphyrin metabolism in man. (1971) (28)
Metabolic impairment and recovery time in acute ethanol intoxication. (1971) (27)
Influence of growth hormone on the synthesis of rat liver alcohol dehydrogenase in primary hepatocyte culture. (1989) (27)
Effect of growth hormone on alcohol dehydrogenase activity in hepatocyte culture (1986) (27)
Effect of 4-(diethylamino)benzaldehyde on ethanol metabolism in mice. (1993) (27)
Effect of castration on the turnover of rat liver alcohol dehydrogenase. (1985) (27)
Vitamin B6 metabolism in chronic alcohol abuse (1976) (27)
CCAAT/enhancer binding protein binds and activates the promoter of the rat class I alcohol dehydrogenase gene. (1991) (26)
Animal models for alcoholic liver disease (1989) (26)
Effects of phenobarbital administration on rates of ethanol clearance and on ethanol-oxidizing enzymes in man. (1974) (26)
A transient increase in c-myc precedes the transdifferentiation of hepatic stellate cells to myofibroblast-like cells. (1999) (25)
Regulation of the rat class I alcohol dehydrogenase gene by growth hormone. (1993) (25)
Influence of sex hormones on alcohol metabolism. (2000) (24)
Identification of a novel NF-kappaB-binding site with regulation of the murine alpha2(I) collagen promoter. (2004) (23)
Effects of vitamin D3 stimulation of thioredoxin‐interacting protein in hepatocellular carcinoma (2014) (23)
Deregulation of energy metabolism promotes antifibrotic effects in human hepatic stellate cells and prevents liver fibrosis in a mouse model. (2016) (23)
Effect of uremia on rates of ethanol disappearance from the blood and on the activities of the ethanol-oxidizing enzymes. (1975) (23)
Liver alcohol dehydrogenase activity in the female rat: effects of ovariectomy and estradiol administration. (1981) (23)
Influences of reactive oxygen species and nitric oxide on hepatic fibrogenesis (2006) (22)
Effect of Acetaldehyde on Sp1 Binding and Activation of the Mouse α2(I) Collagen Promoter (1997) (22)
Elevated mitochondrial activity distinguishes fibrogenic hepatic stellate cells and sensitizes for selective inhibition by mitotropic doxorubicin (2018) (22)
Regulation of alpha 2(I) collagen expression in stellate cells by retinoic acid and retinoid X receptors through interactions with their cofactors. (2004) (22)
Effects of acetaldehyde and TNFα on the inhibitory kappa B- α protein and nuclear factor kappa B activation in hepatic stellate cells (2005) (21)
The first 22 base pairs of the proximal promoter of the rat class I alcohol dehydrogenase gene is bipartite and interacts with multiple DNA-binding proteins. (1992) (21)
Leptin deficiency reduces but does not eliminate the development of hepatic fibrosis in mice infected with Schistosoma mansoni. (2002) (20)
Jejunal uptake of tritiated folic acid in the rat studied by in vivo perfusion. (1974) (20)
Effect of leptin on liver alcohol dehydrogenase. (2005) (20)
Effect of ethanol feeding on hepatic lysosomes in the monkey. (1980) (18)
Biliary excretion of alcohol dehydrogenase. (1968) (18)
Ethanol-induced increases in [Ca2+]i and inositol (1,4,5) triphosphate in rat hepatocytes. (1990) (18)
Endotoxin Enhances Liver Alcohol Dehydrogenase by Action through Upstream Stimulatory Factor but Not by Nuclear Factor-κB* (2003) (18)
Regulation of the murine alpha(2)(I) collagen promoter by retinoic acid and retinoid X receptors. (2002) (18)
Changes in plasma amino acids during sobriety in alcoholic patients with and without liver disease. (1986) (17)
Liver alcohol dehydrogenase is degraded by the ubiquitin-proteasome pathway. (2001) (16)
Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients (2022) (16)
Effect of phenobarbital administration on ethanol oxidizing enzymes and on the rates of ethanol degradation. (1971) (16)
Acetaldehyde increases endogenous adiponectin and fibrogenesis in hepatic stellate cells but exogenous adiponectin inhibits fibrogenesis. (2007) (16)
Effect of ethanol feeding on bone composition in the rat. (1979) (15)
Treatment of alcoholic liver disease. (1993) (15)
Alcohol dehydrogenase activity in the uremic rat. (1978) (14)
Liver disease and nutrition. (1978) (14)
Assessing liver fibrosis: Comparison of arterial enhancement fraction and diffusion‐weighted imaging (2014) (14)
Effects of acetaldehyde and TNF alpha on the inhibitory kappa B-alpha protein and nuclear factor kappa B activation in hepatic stellate cells. (2005) (13)
Effect of retinoic acid on the enhancing effect of acetaldehyde on mouse type I collagen expression. (2000) (13)
Effects of acetaldehyde on hepatocyte glycerol uptake and cell size: implication of aquaporin 9. (2011) (13)
Effect of dihydrotestosterone on turnover of alcohol dehydrogenase in rat hepatocyte culture (1998) (13)
Detection and localization of immunoreactive alcohol dehydrogenase protein in the rat testis. (1988) (13)
Commentary on the hypermetabolic state and the role of oxygen in alcohol-induced liver injury. (1984) (13)
Identification of Two Repressor Elements in the Mouse α2(I) Collagen Promoter (1999) (13)
Effect of acute intravenous alcohol on plasma lipoproteins in man. (1991) (13)
Effect of insulin-like growth factor I on rat alcohol dehydrogenase in primary hepatocyte culture. (1990) (12)
Hepatic collagen proline hydroxylase activity in hepatic disease following jejunoileal bypass for morbid obesity. (1978) (12)
Effect of epinephrine on ethanol metabolism by isolated rat hepatocytes. (1990) (12)
Characterization of human erythrocyte aldehyde dehydrogenase. (1987) (12)
A case of severe benign intrahepatic cholestasis treated with liver transplantation (2002) (12)
Effect of testosterone administration on rates of ethanol elimination in hypogonadal patients. (1989) (12)
The effects of variation in dietary protein and ethanol on hepatic microsomal drug metabolism in the rat (1981) (12)
Effect of glucagon on alcohol dehydrogenase activity in rat hepatocyte culture. (1986) (11)
Actions and interactions of ethanol with drugs on intermediary metabolism. (1981) (11)
Induction of alcohol withdrawal symptoms by nalorphine in chronic alcoholic patients. (1978) (11)
CCAAT/enhancer binding protein beta mediates the activation of the murine alpha1(I) collagen promoter by acetaldehyde. (2000) (11)
Increased urinary excretion of D-glucaric acid in alcoholism. (1976) (10)
The Combination of Selenium and Vitamin E Inhibits Type I Collagen Formation in Cultured Hepatic Stellate Cells (2011) (10)
Stress and ethanol metabolism. (1998) (10)
Effect of thyroidectomy on liver alcohol dehydrogenase in the female rat. (1983) (10)
Effects of chronic ethanol feeding on enzymes of rat brain and liver mitochondria. (1972) (10)
Enhancer-site downstream binding protein activity is enriched in rat tissues that express the class I alcohol dehydrogenase gene. (1992) (10)
Changes in endocrine pancreatic function produced by altered dietary protein intake in drinking alcoholics. (1976) (10)
Trauma in cirrhosis: an indicator of the pattern of alcohol abuse in different societies. (1991) (9)
Regulation of rat alcohol dehydrogenase by cyclic AMP in primary hepatocyte culture. (1995) (9)
Effects of a choline-deficient diet on the induction of drug- and ethanol-metabolizing enzymes and on the alteration of rates of ethanol degradation by ethanol and phenobarbital. (1975) (9)
Identification of new sites of binding and activation of the murine α1(I) collagen promoter by CCAAT/enhancer binding protein β (2001) (9)
Activation of the human alpha1(I) collagen promoter by leptin is not mediated by transforming growth factor beta responsive elements. (2003) (9)
Hormonal regulation of the rat class I alcohol dehydrogenase gene. (1993) (9)
Activation of the human α1(I) collagen promoter by leptin is not mediated by transforming growth factor β responsive elements (2003) (9)
225 A randomized placebo controlled trial of vitamin E in alcoholic hepatitis (2003) (8)
Prevention of alcohol-induced hepatic fibrosis by phosphatidylcholine. (1994) (7)
Effect of STAT5b on rat liver alcohol dehydrogenase. (2001) (7)
The source of the nothing dehydrogenase activity in normal serum. (1969) (7)
[Therapy of alcoholism]. (1976) (6)
Pyridoxine deficiency and ethanol-induced liver injury. (1987) (6)
Effects of thyroidectomy and triiodothyronine administration on rat liver alcohol dehydrogenase. (1981) (6)
Influence of epinephrine on alcohol dehydrogenase activity in rat hepatocyte culture. (1988) (6)
Loss of the characteristic features of atypical human liver alcohol dehydrogenase during purification. (1969) (6)
Medical problems associated with alcoholism. (1974) (5)
Identification of new sites of binding and activation of the murine alpha1(I) collagen promoter by CCAAT/enhancer binding protein beta. (2001) (5)
Erratum: Transdifferentiation of Rat Hepatic Stellate Cells Results in Leptin Expression (Biochemical and Biophysical Research Communications (1998) 244, 1 (178-182)) (1998) (5)
The effect of vitamin E on porphyrinuria induced by ethanol in the rat. (1971) (5)
Acetaldehyde activates the promoter of the mouse alpha 2(I) collagen gene. (1994) (4)
Approaches to treatment of fibrogenesis in alcoholic liver disease. (1991) (4)
19 – EFFECTS OF ALCOHOL ON GASTROINTESTINAL AND PANCREATIC FUNCTION IN ALCOHOLICS (1979) (4)
The adult enhancer factor-1, a Drosophila melanogaster transcriptional repressor, modulates the promoter activity of the rat class-I alcohol dehydrogenase-encoding gene. (1994) (4)
Ethanol and H2‐receptor antagonists (1985) (4)
Effect of acute alcohol administration on erythrocyte aldehyde dehydrogenase activity in man. (1986) (4)
Is the pathway of energy metabolism modified in advanced cirrhosis? (2014) (4)
Effect of acetaldehyde on Sp1 binding and activation of the mouse alpha 2(I) collagen promoter. (1997) (4)
Alcoholic liver disease. (1982) (4)
Insulin growth factor I and hypogonadism in cirrhosis (2000) (3)
Ratio of plasma α-amino-n-butyric acid to leucine in alcoholism (1978) (3)
Changes in erythrocyte enzyme activities during erythrocyte aging in alcoholism. (1988) (3)
Alcohol and drug interactions in injury to the digestive tract. (1981) (3)
Altered expression of HLA antigens and CD16 Fc receptors on leukocytes of alcoholic subjects and uremic patients. (1991) (3)
Comparison of nutritional background of the patients with alcoholic liver diseases between U.S.A. and Japan. (1989) (3)
Alcohol and Acetaldehyde Metabolism: Concluding Remarks (1987) (3)
20 – LIVER ABNORMALITIES IN ALCOHOLISM: ALCOHOL CONSUMPTION AND NUTRITION (1979) (3)
Leptin deficiency prevents the activation of the murine α2(I) collagen promoter by acetaldehyde (2004) (3)
Identification of two repressor elements in the mouse alpha 2(I) collagen promoter. (1999) (3)
Effect of ethanol on hepatic proline-metabolizing enzymes in the rat. (1981) (3)
Measurement of alcohol-related effects in man: chronic effects in relation to levels of alcohol consumption. Part B. (1977) (2)
Animal models for alcoholic liver disease (1989) (2)
Management of alcoholism. (1976) (2)
Effect of Nitric Oxide on Type I Collagen Expression in Cultured Stellate Cells (2008) (2)
Leptin deficiency prevents the activation of the murine alpaha 2(I) collagen promoter by acetaldehyde. (2004) (2)
Ethanol and Hepatic Fibrogenesis (1979) (2)
Alcohol consumption and γ-glutamyltransferase activity (1978) (2)
A case of severe benign intrahepatic cholestasis treated with liver transplantation. (2002) (2)
Ethanol and nitrogen metabolism. (1978) (2)
Retinoids and alcoholic liver disease. (1997) (2)
SEX HORMONES AND ALCOHOL METABOLISM (1998) (1)
Intoxicated enterocytes? (1972) (1)
ACETALDEHYDE, LIVER INJURY, AND JEJUNOILEAL BYPASS (1983) (1)
Hepatic iron in hemochromatosis and alcoholism (1983) (1)
Effect of D-penicillamine on hepatic collagen proline hydroxylase activity in alcoholic hepatitis (1978) (1)
Alcohol metabolism in men and women (Reply) (1990) (1)
Ethanol and amino acid uptake by hepatocytes (1987) (1)
A novel NFKB1 promoter polymorphism shows altered binding to nuclear proteins and increases risk for ulcerative colitis (2003) (1)
Alcohol Nutrition and the Nervous System (1986) (1)
Alcohol Metabolism during Development (1974) (0)
B. MECHANISMS OF LIVER DAMAGE IN ALCOHOLISM: ASSESSMENT OF KNOWN FACTORS (1981) (0)
Portal-systemic encephalopathy: Combes B, Conn HO, Schenker S. Produced by Merrell-National Laboratories, 1975. Available from Merrell-National Laboratories, Film Library, Cincinnati, Ohio 45203. Running time, 25 min; 16 mm sound film in color. Free loan (1978) (0)
Effects of ethanol and variation in dietary protein on microsomal function (1980) (0)
Hepatic acid phosphatase after ethanol feeding in the monkey (1978) (0)
850d Human bile contains microRNA-laden exosomes that can be used for cholangiocarcinoma diagnosis (2014) (0)
Prevention of alcohol-induced fatty liver (1978) (0)
Sex difference in alcohol-related organ injury. Review (2001) (0)
Ratio of plasma alpha-amino-n-butyric acid to leucine in alcoholism. (1978) (0)
Sa1102 Refractory Anemia Due to Pyridoxine Deficiency in Patients With Crohn's Disease or Cirrhosis (2012) (0)
Fulminant Liver Failure Due to Acute Hepatitis C Infection in the Setting of AIDS: 1318 (2014) (0)
739 MicroRNA-494 is Downregulated in Human CCA and Controls G1 to S Transition Through Multiple Targets (2012) (0)
Human liver alcohol dehydrogenase (1978) (0)
[Treatment of experimental liver injury with a Chinese herbal medicine tablet]. (1986) (0)
Reply of the author: Pancreatic Exocrine Function in Chronic Alcoholics (1971) (0)
490f – Liver Cancer Organoids Model Drug Response Heterogeneity (2019) (0)
490e – Complext Patient Derived Organoids(CPDOS) Modeling for Anti-Cancer Drug Screening (2019) (0)
Urea synthesis in cirrhosis (1979) (0)
Hepatic acetaldehyde dehydrogenase in alcoholism (1983) (0)
Ethanol increases ADP-ribosylation of histones in rat hepatocyte nuclei. (1993) (0)
Abstract 5284: A microRNA downregulated in human cholangiocarcinoma induces G2/M arrest through multiple targets. (2013) (0)
Nutritional Effects of Hepatic Failure (1979) (0)
M1583 Inhibition of NADPH Oxidase Suppresses Fibrogenesis (2008) (0)
Metabolic interactions of nutrition and drugs (1985) (0)
Bypassed bowel and liver disease (1980) (0)
Acetaldehyde potentiates protein kinase C activity in rat myofibroblast-like cells (1996) (0)
Ehanol and liver regeneration (1981) (0)
Diseases of the Liver (2012) (0)
Diseases of the Biliary Tract (1940) (0)
Alcohol and renal vitamin D metabolism (1980) (0)
Treatment of Experimental Liver Injury with Chinese Herbal Medicine Queen Tablet (1986) (0)
Letter: Blood alcohol. (1974) (0)
Ethanol metabolism and tolerance in man: the effects of age (1975) (0)
Effect of ethanol on folate transport by hepatocytes (1980) (0)
Augmented Liver Uptake of the Membrane Voltage Sensor Tetraphenylphosphonium Distinguishes Early Fibrosis in a Mouse Model (2021) (0)
Portal-systemic encephalopathy (1978) (0)
Alcohol consumption and mortality (1980) (0)
Alcohol and liver cell necrosis (1981) (0)
Malnutrition in alcoholic hepatitis (1984) (0)
Serum 2,3-butanediol in alcoholics during acute intoxication (1984) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Esteban Mezey?

Esteban Mezey is affiliated with the following schools:

Johns Hopkins University